Centene Health Care Fraud Case: How Private Lawyers Profited
A group of politically connected lawyers teamed up to go after insurers and made millions from one of the largest Medicaid settlements in history.
Oprah — and America — Embrace the Promise of Ozempic
Her special is a harbinger of how the weight-loss industry is rebranding: Obesity is a disease, and — for the first time — it’s not your fault.
A Psychedelics Reporter With a Changing Perspective
Can an experimental drug cure opioid addiction? Andrew Jacobs, who writes about psychedelic medicine for The Times, explored the “promise and peril” of ibogaine.
The High Cost of Weight-Loss Drugs
Readers discuss the costs and benefits. Also: Donald Trump’s remark about American Jews and Israel; subway shootings; abortion providers; FAFSA chaos.
‘What’s My Life Worth?’ The Big Business of Denying Medical Care
Insurance companies have weaponized a seemingly benign process to protect their profits, and it’s putting patients at risk.
Oregon Decriminalized Drugs. Voters Now Regret It.
State lawmakers are about to reverse course, making the possession of hard narcotics an offense again.
The Challenges of Teaching Constitutional Law Today
Readers discuss an Opinion piece about a politicized Supreme Court. Also: Trump’s mockery of Biden; fans of the president; alcoholism; great literature.
Lo que hay que saber sobre la ibogaína
Algunos investigadores esperan que la droga, aún ilegal en Estados Unidos, pueda considerarse como tratamiento para la adicción, el trastorno de estrés postraumático y las lesiones cerebrales.
With Cyberattack Fix Weeks Away, Health Providers Slam United
Hospitals, doctors and clinics expressed frustration that they will have to wait even longer for reimbursements after hackers paralyzed the largest U.S. billing clearinghouse.
A.L.S. Drug Relyvrio Fails Clinical Trial and May Be Withdrawn From the Market
Leaders of the treatment’s manufacturer, Amylyx, said they would announce their plans for it within eight weeks.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.